CTS Corporation (CTS) is a publicly traded Technology sector company. As of May 21, 2026, CTS trades at $60.88 with a market cap of $1.63B and a P/E ratio of 24.88. CTS moved +4.07% today. Year to date, CTS is +33.51%; over the trailing twelve months it is +40.88%. Its 52-week range spans $34.02 to $62.02. Rallies surfaces CTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in CTS news today?
CTS Corporation Posts 11% Q1 Sales Growth and 250bp Margin Expansion: CTS Corporation generated $139.2 million in Q1 revenue with net income of $17.2 million, driving an 11% sales increase and a 250-basis-point gross margin expansion. The company reported a 1.1 book-to-bill ratio led by industrial and medical markets and narrowed 2026 sales guidance to $560–$580 million.
Agrawal Ashish sold 25.00K (~$1.32M) on Feb 2, 2026.
O'SULLIVAN KIERAN M sold 6.69K (~$373.48K) on Dec 9, 2024.
O'SULLIVAN KIERAN M sold 8.49K (~$462.90K) on Dec 6, 2024.
CTS Analyst Consensus
CTS analyst coverage data. Average price target: $0.00.
Common questions about CTS
What changed in CTS news today?
CTS Corporation Posts 11% Q1 Sales Growth and 250bp Margin Expansion: CTS Corporation generated $139.2 million in Q1 revenue with net income of $17.2 million, driving an 11% sales increase and a 250-basis-point gross margin expansion. The company reported a 1.1 book-to-bill ratio led by industrial and medical markets and narrowed 2026 sales guidance to $560–$580 million.
Does Rallies summarize CTS news?
Yes. Rallies summarizes CTS news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is CTS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CTS. It does not provide personalized investment advice.
